W Jeffrey Allard

Summary

Publications

  1. ncbi Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    W Jeffrey Allard
    Immunicon Corporation, Huntingdon Valley, Pennsylvania 19006, USA
    Clin Cancer Res 10:6897-904. 2004
  2. ncbi Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    Massimo Cristofanilli
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    N Engl J Med 351:781-91. 2004
  3. ncbi Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
    Massimo Cristofanilli
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 424, Houston, TX 77030, USA
    J Clin Oncol 23:1420-30. 2005
  4. ncbi Circulating tumor cells predict survival in patients with metastatic prostate cancer
    Jose G Moreno
    Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Urology 65:713-8. 2005
  5. ncbi Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
    Daniel F Hayes
    Department of Internal Medicine and the Comprehensive Cancer Center, University of Michigan Health and Hospital System, Ann Arbor, Michigan 48109, USA
    Clin Cancer Res 12:4218-24. 2006
  6. ncbi Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
    Steven J Cohen
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Clin Colorectal Cancer 6:125-32. 2006

Collaborators

Detail Information

Publications6

  1. ncbi Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    W Jeffrey Allard
    Immunicon Corporation, Huntingdon Valley, Pennsylvania 19006, USA
    Clin Cancer Res 10:6897-904. 2004
    ..5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas...
  2. ncbi Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    Massimo Cristofanilli
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    N Engl J Med 351:781-91. 2004
    ..We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer...
  3. ncbi Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
    Massimo Cristofanilli
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 424, Houston, TX 77030, USA
    J Clin Oncol 23:1420-30. 2005
    ....
  4. ncbi Circulating tumor cells predict survival in patients with metastatic prostate cancer
    Jose G Moreno
    Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Urology 65:713-8. 2005
    ..CONCLUSIONS: In this pilot study, the presence of 5 or more CTCs in 7.5 mL blood was associated with poor overall survival in patients with metastatic PCa...
  5. ncbi Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
    Daniel F Hayes
    Department of Internal Medicine and the Comprehensive Cancer Center, University of Michigan Health and Hospital System, Ann Arbor, Michigan 48109, USA
    Clin Cancer Res 12:4218-24. 2006
    ..In this study, additional follow-up data and CTC levels at subsequent follow-up visits were evaluated...
  6. ncbi Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
    Steven J Cohen
    Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111 2497, USA
    Clin Colorectal Cancer 6:125-32. 2006
    ....